255 related articles for article (PubMed ID: 24947931)
1. Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.
Armenian SH; Gelehrter SK; Vase T; Venkatramani R; Landier W; Wilson KD; Herrera C; Reichman L; Menteer JD; Mascarenhas L; Freyer DR; Venkataraman K; Bhatia S
Clin Cancer Res; 2014 Dec; 20(24):6314-23. PubMed ID: 24947931
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of a Novel Handheld Wireless Platform for Detection of Cardiac Dysfunction in Anthracycline-Exposed Survivors of Childhood Cancer.
Armenian SH; Rinderknecht D; Au K; Lindenfeld L; Mills G; Siyahian A; Herrera C; Wilson K; Venkataraman K; Mascarenhas K; Tavallali P; Razavi M; Pahlevan N; Detterich J; Bhatia S; Gharib M
Clin Cancer Res; 2018 Jul; 24(13):3119-3125. PubMed ID: 29929955
[No Abstract] [Full Text] [Related]
3. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.
Armenian SH; Hudson MM; Chen MH; Colan SD; Lindenfeld L; Mills G; Siyahian A; Gelehrter S; Dang H; Hein W; Green DM; Robison LL; Wong FL; Douglas PS; Bhatia S
BMC Cardiovasc Disord; 2016 Oct; 16(1):187. PubMed ID: 27716152
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review.
Leerink JM; Verkleij SJ; Feijen EAM; Mavinkurve-Groothuis AMC; Pourier MS; Ylänen K; Tissing WJE; Louwerens M; van den Heuvel MM; van Dulmen-den Broeder E; de Vries ACH; Ronckers CM; van der Pal HJH; Kapusta L; Loonen J; Bellersen L; Pinto YM; Kremer LCM; Kok WEM
Heart; 2019 Feb; 105(3):210-216. PubMed ID: 30158136
[TBL] [Abstract][Full Text] [Related]
5. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
[TBL] [Abstract][Full Text] [Related]
6. Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.
Mladosievicova B; Urbanova D; Radvanska E; Slavkovsky P; Simkova I
J Exp Clin Cancer Res; 2012 Oct; 31(1):86. PubMed ID: 23057994
[TBL] [Abstract][Full Text] [Related]
7. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
8. Long-term cardiac effects of treatment for childhood leukemia.
Urbanova D; Urban L; Simkova I; Danova K; Mikuskova E; Mladosievicova B
Neoplasma; 2010; 57(2):179-83. PubMed ID: 20099983
[TBL] [Abstract][Full Text] [Related]
9. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
[TBL] [Abstract][Full Text] [Related]
10. Cardiac dysfunction in cancer survivors unmasked during exercise.
Kearney MC; Gallop-Evans E; Cockcroft JR; Stöhr EJ; Lee E; Backx K; Haykowsky M; Yousef Z; Shave R
Eur J Clin Invest; 2017 Mar; 47(3):213-220. PubMed ID: 28036108
[TBL] [Abstract][Full Text] [Related]
11. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia.
Christiansen JR; Kanellopoulos A; Lund MB; Massey R; Dalen H; Kiserud CE; Ruud E; Aakhus S
Pediatr Blood Cancer; 2015 Aug; 62(8):1437-43. PubMed ID: 25832752
[TBL] [Abstract][Full Text] [Related]
12. Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study.
Landy DC; Miller TL; Lipsitz SR; Lopez-Mitnik G; Hinkle AS; Constine LS; Adams MJ; Lipshultz SE
Pediatr Cardiol; 2013 Apr; 34(4):826-34. PubMed ID: 23080542
[TBL] [Abstract][Full Text] [Related]
13. New three-dimensional speckle-tracking echocardiography identifies global impairment of left ventricular mechanics with a high sensitivity in childhood cancer survivors.
Yu HK; Yu W; Cheuk DK; Wong SJ; Chan GC; Cheung YF
J Am Soc Echocardiogr; 2013 Aug; 26(8):846-52. PubMed ID: 23727115
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.
Lipshultz SE; Landy DC; Lopez-Mitnik G; Lipsitz SR; Hinkle AS; Constine LS; French CA; Rovitelli AM; Proukou C; Adams MJ; Miller TL
J Clin Oncol; 2012 Apr; 30(10):1050-7. PubMed ID: 22393080
[TBL] [Abstract][Full Text] [Related]
15. Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy.
Santin JC; Deheinzelin D; Junior SP; Lopes LF; de Camargo B
J Pediatr Hematol Oncol; 2007 Nov; 29(11):761-5. PubMed ID: 17984694
[TBL] [Abstract][Full Text] [Related]
16. Assessing the left atrium of childhood cancer survivors.
Loar RW; Colquitt JL; Rainusso NC; Gramatges MM; Liu AM; Noel CV; Tunuguntla HP; Lilje C; Pignatelli RH
Int J Cardiovasc Imaging; 2021 Jan; 37(1):155-162. PubMed ID: 32803485
[TBL] [Abstract][Full Text] [Related]
17. Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis.
Michel L; Mincu RI; Mrotzek SM; Korste S; Neudorf U; Rassaf T; Totzeck M
ESC Heart Fail; 2020 Apr; 7(2):423-433. PubMed ID: 32069386
[TBL] [Abstract][Full Text] [Related]
18. Myocardial 2D Strain During Long-Term (>5 Years) Follow-Up of Childhood Survivors of Acute Lymphoblastic Leukemia Treated With Anthracyclines.
Pourier MS; Mavinkurve-Groothuis AMC; Dull MM; Weijers G; Loonen J; Bellersen L; de Korte CL; Kapusta L
Am J Cardiol; 2020 Jul; 127():163-168. PubMed ID: 32444028
[TBL] [Abstract][Full Text] [Related]
19. New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy.
Shigemitsu S; Takahashi K; Yazaki K; Kobayashi M; Yamada M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Itatani K; Shimizu T
Heart Vessels; 2019 Jun; 34(6):992-1001. PubMed ID: 30673819
[TBL] [Abstract][Full Text] [Related]
20. Speckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer.
Ylänen K; Eerola A; Vettenranta K; Poutanen T
Eur J Pediatr; 2016 Oct; 175(10):1379-86. PubMed ID: 27620626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]